[go: up one dir, main page]

WO2005074709A2 - Denrees alimentaires enrichies en calcium - Google Patents

Denrees alimentaires enrichies en calcium Download PDF

Info

Publication number
WO2005074709A2
WO2005074709A2 PCT/EP2005/000903 EP2005000903W WO2005074709A2 WO 2005074709 A2 WO2005074709 A2 WO 2005074709A2 EP 2005000903 W EP2005000903 W EP 2005000903W WO 2005074709 A2 WO2005074709 A2 WO 2005074709A2
Authority
WO
WIPO (PCT)
Prior art keywords
food
calcium content
calcium
foods
food according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/000903
Other languages
German (de)
English (en)
Other versions
WO2005074709A3 (fr
Inventor
Anton HÄRLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2005074709A2 publication Critical patent/WO2005074709A2/fr
Publication of WO2005074709A3 publication Critical patent/WO2005074709A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/09—Other cheese preparations; Mixtures of cheese with other foodstuffs
    • A23C19/0921—Addition, to cheese or curd, of minerals, including organic salts thereof, trace elements, amino acids, peptides, protein hydrolysates, nucleic acids, yeast extracts or autolysate, vitamins or derivatives of these compounds
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/145—Acids, anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/101—Addition of antibiotics, vitamins, amino-acids, or minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • osteoporosis Around 5 million people in the Federal Republic of Germany suffer from bone loss that occurs in middle age and is known as osteoporosis. The most common complication in osteoporosis is vertebral body fractures, which in the Federal Republic of Germany are approx. 1.7 million women and approx. 800,000 men are affected. Many of these vertebral body collapses are gradual and progressive, with the person barely knowing that such an event has occurred. Other patients only have short-term back pain, but the majority of patients suffer so severely in the acute stage of vertebral body spraining that they need medical treatment. Once a vertebral fracture has occurred, the risk of fracture increases significantly for the affected patient. The fact that the rear elements of the vertebral bodies are more resistant than the front sections leads to the formation of the age hump and a reduction in the original body size.
  • the next common bone fracture in osteoporosis is the femoral neck fracture, which in the FRG with approx. 150,000 cases per year occur much less frequently, but it is a clinically very important event that always requires medical, mostly surgical treatment.
  • the problem is the overall mortality associated with this disease, which in 1999 was based on a study on approx. 22% was estimated.
  • a range of € 13,000 to € 30,000 per femoral neck fracture is specified for the treatment costs. For Switzerland, it is published that osteoporosis causes costs of € 1.3 billion / year with an increasing trend.
  • the prophylactic, medicinal treatment of osteoporosis before the first vertebral body fracture occurred has evolved according to evidence-based consensus guidelines.
  • basic therapy with supplementation of 1,000 mg calcium in conjunction with 400 - 800 IU vitamin D3 is used and administered with medication if the change in diet to calcium-rich diet and the vitamin D supply do not appear to be promising.
  • additional therapy with active substances that influence bone metabolism is recommended for women who are older than 75 years or who have risk factors for postmenopausal osteoporosis. The decisive changes therefore take place long before the first fracture manifestation.
  • the calcium supply in food should be made using salts of weak acids, which establish such an environment during dissociation.
  • the desired calcium concentration can be obtained by adding the calcium salt directly to the food or its precursor.
  • the desired calcium content of a food can also be set by adding ingredients that are used for the production of food, such as spices and other parts of plants which have a very high calcium content, such as sesame, basil, etc., in the production of the food become.
  • Particularly suitable for the manufacturing process are water-soluble calcium salts which, in aqueous solution, set a slightly acidic pH and thereby promote calcium absorption in the intestine.
  • the acid component of which can be metabolized in the body it would be advisable to add such calcium salts use, the acid component of which can be metabolized in the body.
  • calcium salts of weak acids the acid components of which can be broken down in the course of cell metabolism, appear particularly suitable, such as calcium carbonate, calcium hydrogen carbonate or calcium citrate and the like.
  • Calcium enrichment has to be differentiated for the different food groups. With these calcium-enriched foods, an increase in calcium intake can be achieved, as it were, passively with food intake, in order to effectively counteract the bone loss occurring in the aging process and in osteoporosis.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Noodles (AREA)

Abstract

L'invention concerne des denrées alimentaires enrichies en calcium, se présentant sous différentes formes, notamment sous la forme de denrées alimentaires de base, à base de produits céréaliers. Pour augmenter la teneur en calcium de ces denrées alimentaires, des sels de calcium hydrosolubles d'acides faibles ont été ajoutés auxdites denrées alimentaires, au cours du processus de fabrication, dans des quantités telles qu'une concentration minimale déterminée de ce minéral soit contenue dans la denrée alimentaire concernée. L'enrichissement en calcium est réalisé de manière différenciée pour les différents groupes de denrées alimentaires. L'objectif de l'invention est de permettre, au moyen de ces denrées alimentaires enrichies en calcium, d'augmenter l'absorption de calcium lors de l'absorption d'aliments, afin de lutter contre une maladie répandue, l'ostéoporose. L'invention concerne, outre lesdites denrées alimentaires, le procédé de production de ces dernières.
PCT/EP2005/000903 2004-02-04 2005-01-31 Denrees alimentaires enrichies en calcium Ceased WO2005074709A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004005338A DE102004005338A1 (de) 2004-02-04 2004-02-04 Kalzium-Angereicherte Lebensmittel
DE102004005338.3 2004-02-04

Publications (2)

Publication Number Publication Date
WO2005074709A2 true WO2005074709A2 (fr) 2005-08-18
WO2005074709A3 WO2005074709A3 (fr) 2006-03-02

Family

ID=34801510

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/000903 Ceased WO2005074709A2 (fr) 2004-02-04 2005-01-31 Denrees alimentaires enrichies en calcium

Country Status (2)

Country Link
DE (1) DE102004005338A1 (fr)
WO (1) WO2005074709A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111000255A (zh) * 2019-11-05 2020-04-14 北京雪域圣肽生物科技有限公司 一种适用于中老年的高钙乳清牦牛乳蛋白粉及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008049172A1 (de) 2007-11-22 2009-10-15 Human Nutrition Gmbh Diätetisches Lebensmittel
DE102011012985A1 (de) 2010-03-19 2011-09-22 Human Nutrition Gmbh Kleingebäck mit hohem Eiweißgehalt
DE102012008271A1 (de) 2012-04-23 2013-10-24 Human Nutrition Gmbh Kleingebäck zur Unterstützung der Gewichtsreduktion

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01304854A (ja) * 1988-06-01 1989-12-08 Sunstar Inc ゼラチンゼリー食品
JPH05304928A (ja) * 1992-04-29 1993-11-19 Aroma Kagaku Kikai Kogyo:Kk カルシウム添加食品の製造方法
JP3282771B2 (ja) * 1994-08-30 2002-05-20 寳酒造株式会社 パン類用固形カルシウム剤
US5514387A (en) * 1994-11-29 1996-05-07 Nabisco, Inc. Calcium-enriched baked good production and method of making
CN1072441C (zh) * 1996-09-13 2001-10-10 哈尔滨多元超细粉体工程有限责任公司 钙营养强化面粉
US5840354A (en) * 1997-06-03 1998-11-24 General Mills, Inc. Dried fruit products fortified with calcium and method of preparation
US6036985A (en) * 1998-04-03 2000-03-14 Nestec S.A. Calcium complex and food fortified therewith
US6210720B1 (en) * 1999-09-22 2001-04-03 General Mills, Inc. Calcium fortified cereal product and method of preparation
US6261610B1 (en) * 1999-09-24 2001-07-17 Nestec S.A. Calcium-magnesium fortified water, juices, beverages and other liquid food products and process of making
JP4484992B2 (ja) * 1999-12-24 2010-06-16 丸尾カルシウム株式会社 食品添加剤スラリー組成物及びパウダー組成物、並びにこれらを含有する食品組成物
US6599544B2 (en) * 2000-01-26 2003-07-29 American Micronutrients, Inc. Calcium enrichment composition and method for producing the same
US6326038B1 (en) * 2000-03-27 2001-12-04 Kraft Foods, Inc. Calcium fortification of cheese
JP2001302522A (ja) * 2000-04-28 2001-10-31 Q P Corp 骨粗しょう症抑制剤及びこれを用いた食品
US6913775B2 (en) * 2000-05-05 2005-07-05 General Mills, Inc. Cooked cereal dough products fortified with calcium and method of preparation
CA2419662A1 (fr) * 2000-08-15 2002-02-21 Alfonso Maldonado Produits de boulangerie enrichis en mineraux
CN1440661A (zh) * 2002-02-25 2003-09-10 刘振民 一种钙强化面粉
CN1502246A (zh) * 2002-11-25 2004-06-09 立 朱 全营养面包

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111000255A (zh) * 2019-11-05 2020-04-14 北京雪域圣肽生物科技有限公司 一种适用于中老年的高钙乳清牦牛乳蛋白粉及其制备方法

Also Published As

Publication number Publication date
WO2005074709A3 (fr) 2006-03-02
DE102004005338A1 (de) 2005-08-25

Similar Documents

Publication Publication Date Title
DE69703839T2 (de) Zusammensetzung, die als nahrungsmittel oder zur senkung des serumlipidspiegels geeignet ist
DE502007010071C5 (de) Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden
US5453282A (en) Dietary lipid digestion-absorption inhibitory agents and ingesta
DE60119891T2 (de) Zusammensetzung zur verminderung geistiger ermüdung
US8703209B2 (en) Composition and method for modulating hydrogen ion physiology
CN106659220A (zh) 营养组合物
DE3348165C2 (fr)
CN101147527A (zh) 一种能使鸭蛋具有软化血管和降压作用的饲料及制备方法
DE212011100215U1 (de) Ernährungsprodukt, umfassend ein Biguanid
WO2005074709A2 (fr) Denrees alimentaires enrichies en calcium
WO2006132042A1 (fr) Poudre de complément alimentaire et graisse destinées aux aliments ou aux médicaments
WO2007132714A1 (fr) Agent servant à accroître la densité osseuse
DE102005033630A1 (de) Calcium-Peptid-Komponente
EP0875156B1 (fr) Proudits pour soutenir le traitement de dermatite atopique
US20100028457A1 (en) Agent for prevention or treatment of blood glucose level elevation
JP2008143811A (ja) 脂質代謝促進組成物
KR20060075040A (ko) 돈육용 배합사료 조성물 및 이를 이용하여 생산된 돈육
EP0374935B1 (fr) Préparation pour prévenir l'ostéoporose et pour traiter l'ostéoporose
DE10352822A1 (de) Verwendung einer zusätzlich fermentierten Getreideschlempe zur Vorbeugung und/oder Behandlung erhöhter Blutzucker-Werte
DE602004010741T2 (de) Verwendung von Monosachharidphosphaten zur Verbesserung der intestinalen Funktion
KR20150096089A (ko) 해조칼슘 및 푸마르산제일철을 함유하는 여성용 캔디
RU2277816C2 (ru) Минералосодержащий пищевой продукт функционального назначения
JPH1146720A (ja) カルシウム吸収促進栄養組成物
KR20150028659A (ko) 우슬을 포함한 한우 생햄 제조방법
KR20070006797A (ko) 대나무 추출물을 주성분으로 하는 음료 및 의약

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase